Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | HSP90AB1 | P08238 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.43 |
| ▸ | GAA | P10253 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3487578 | 0.90 | CYP3A4 (0.52) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL349722 | 0.90 | CYP3A4 (0.52) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL29282180 | 0.89 | CYP19A1 (0.45) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL7809366 | 0.89 | CYP19A1 (0.45) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL28616927 | 0.87 | RECQL (0.44) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL27443661 | 0.86 | MAOB (0.43) | CYP1A2CYP2C19HSP90AB1ALDH1A1PTGS1 | |
| SCHEMBL3364490 | 0.85 | ABCG2 (0.54) | MAPTHSD17B10CYP3A4CYP19A1ALDH1A1 | |
| SCHEMBL2781922 | 0.84 | KDM4E (0.54) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL16151244 | 0.84 | KDM4E (0.54) | MEN1KMT2AMAPTHSD17B10CYP3A4 | |
| SCHEMBL8249167 | 0.84 | KDM4E (0.54) | MEN1KMT2AMAPTHSD17B10CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4593859-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | Eresina, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2024073013-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| WO-2024073011-A1 | TOPICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA, LLC (US) | 2024-04-04 | — | — | WO | claimed |
| CN-115928318-A | Preparation method of antibacterial and antiviral packaging material and packaging material using same | 华南农业大学 | 2023-04-07 | — | — | CN | claimed |
| US-11596657-B2 | Use of AhR agonist for the preventive or curative treatment of metabolic syndrome and the associated disorders | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2023-03-07 | — | — | US | claimed |
| US-20190282638-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT (FR) | 2019-09-19 | — | — | US | claimed |
| EP-3522902-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS | Institut National de la Recherche Agronomique (FR) | 2019-08-14 | — | — | EP | claimed |
| WO-2018065132-A1 | USE OF AHR AGONIST FOR THE PREVENTIVE OR CURATIVE TREATMENT OF METABOLIC SYNDROME AND THE ASSOCIATED DISORDERS. | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2018-04-12 | — | — | WO | claimed |
| CN-105884736-B | A kind of method that separation prepares 5 kinds of flavone compounds from falcate crazyweed herb | 中国科学院西北高原生物研究所 | 2018-04-06 | — | — | CN | claimed |
| EP-1893173-B1 | AMINO-OXO-INDOLE-YLIDENE COMPOUNDS FOR USE IN TREATING SCALP SKIN ITCHING | UNILEVER PLC (GB) | 2010-10-06 | — | — | EP | claimed |
| EP-1067913-A4 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE LLC (US) | 2009-03-11 | — | — | EP | claimed |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | CONOPCO, INC. D/B/A UNILEVER | 2008-08-28 | — | — | US | claimed |
| EP-1893173-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING AMINO-OXO-INDOLE-YLIDENE COMPOUNDS | Unilever Plc (GB) | 2008-03-05 | — | — | EP | claimed |
| CN-1839903-A | Pharmaceutical composition containing glabrous sarcandra herb extract and its uses | JIANGXI BOSHILIAN SCIENCE AND (CN) | 2006-10-04 | — | — | CN | claimed |
| WO-2006097191-A1 | HAIR AND/OR SCALP CARE COMPOSITIONS INCORPORATING FLAVONOID COMPOUNDS | UNILEVER PLC (GB) | 2006-09-21 | — | — | WO | claimed |
| EP-1067913-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | Bioresponse, L.L.C. (US) | 2001-01-17 | — | — | EP | claimed |
| US-6086915-A | HEATING THE SOLUBILIZING EMULSIFIER, ADDING SOLVENT AND ONE OR MORE PHOSPHOLIPID SURFACTANTS, DISSOLVING IN THIS SOLUTION ONE OR MORE HYDROPHOBIC PHYTOCHEMICALS, ADDING ENCAPSULATORS, FORMING MICROEMULSION, SPRAY DRYING THE SOLUTION | BIORESPONSE L.L.C. (US) | 2000-07-11 | — | — | US | claimed |
| WO-1999049851-A1 | COMPOSITIONS AND METHODS OF ADJUSTING STEROID HORMONE METABOLISM THROUGH FACILITATED ABSORPTION OF HYDROPHOBIC DIETARY COMPOUNDS | BIORESPONSE, L.L.C. (US) | 1999-10-07 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | COL2A1, COLGALT1, PLOD3 | MEN1 4053/4885KMT2A 1308/4885MAPT 696/4885 |
| US-20080207928-A1 | Hair and/or Scalp Care Compositions Incorporating Flavonoid Compounds | POLR1C, F3, AKR1C3 | MEN1 1463/4885KMT2A 1698/4885MAPT 2140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.